OTCMKTS:SWTUY

SWEDISH ORPHAN/S (SWTUY) Stock Price, News & Analysis

$24.38
-0.29 (-1.18%)
(As of 04/9/2019)
Today's Range
$24.38
$24.38
50-Day Range
$24.38
$24.38
52-Week Range
$18.50
$31.96
Volume
200 shs
Average Volume
1,665 shs
Market Capitalization
$6.64 billion
P/E Ratio
48.76
Dividend Yield
N/A
Price Target
N/A
SWTUY stock logo

About SWEDISH ORPHAN/S Stock (OTCMKTS:SWTUY)

Swedish Orphan Biovitrum AB (publ), an integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haemophilia, inflammation, and genetic and lysosomal diseases. The company offers Elocta to treat haemophilia A; and Alprolix to treat haemophilia B. It also provides Orfadin for the treatment of hereditary tyrosinaemia type 1; and Kineret for the treatment of auto inflammatory condition, as well as Xiapex to treat Dupuytren's contracture and Peyronie's disease. In addition, the company manufactures drug substance for ReFacto AF; and develops BIVV001 and BIVV002 for the treatment of hemophilia. It operates in Sweden, the Middle East, North Africa, Russia, North America, other European countries, and internationally. The company has an agreement with Bioverativ for the development and commercialization of Elocta and Alprolix, as well as XTEN-programs. Swedish Orphan Biovitrum AB (publ) is headquartered in Solna, Sweden.

SWTUY Stock Price History

SWTUY Stock News Headlines

Uncover this 2024 Hidden Gem
Exclusive Report: Uncover a Hidden Investment Gem We’re excited to share a special report on one exceptional, publicly traded company. This company has achieved a remarkable 22+% just this year, outperforming the market and revealing the potential for significant gains.
Death and grief in Swedish children's books
The A.I. story nobody is telling you (Read ASAP)
There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...
Orexo and Sobi agree to advance feasibility study with AmorphOX
See More Headlines
Receive SWTUY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SWEDISH ORPHAN/S and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Private Households
Sub-Industry
N/A
Current Symbol
OTCMKTS:SWTUY
Previous Symbol
NASDAQ:SWTUY
CIK
N/A
Fax
N/A
Employees
902
Year Founded
N/A

Profitability

Net Income
$134.73 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$763.19 million
Cash Flow
$0.70 per share
Book Value
$2.88 per share

Miscellaneous

Free Float
N/A
Market Cap
$6.64 billion
Optionable
Not Optionable
Beta
1.81
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

  • Dr. Guido Oelkers (Age 54)
    CEO & Pres
  • Mr. Henrik Stenqvist (Age 52)
    Chief Financial Officer
  • Ms. Anne Marie de Jonge Schuermans
    Head of Technical Operations
  • Ms. Paula Treutiger (Age 52)
    Head of Communications & Investor Relations
  • Mr. Torbjörn Hallberg (Age 50)
    Gen. Counsel & Head of Legal Affairs

SWTUY Stock Analysis - Frequently Asked Questions

How have SWTUY shares performed in 2024?

SWEDISH ORPHAN/S's stock was trading at $24.38 at the beginning of 2024. Since then, SWTUY stock has increased by 0.0% and is now trading at $24.38.
View the best growth stocks for 2024 here
.

How do I buy shares of SWEDISH ORPHAN/S?

Shares of SWTUY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:SWTUY) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners